Medicure (MCUJF) Depreciation & Amortization (CF) (2009 - 2026)
Medicure's (MCUJF) quarterly Depreciation & Amortization (CF) came in at $75108.2 in Q1 2026, down 5.46% year-on-year from $79448.5 in Q1 2025, and down 13.44% quarter-over-quarter from $86767.4 in Q4 2025.
Medicure (MCUJF) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Medicure's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $75108.2 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 5.46% year-over-year to $75108.2 in Q1 2026; TTM through Mar 2026 was $349478.5, a 8.5% increase from a year earlier, with the FY2025 full-year figure at $353566.4, up 10.52% from the prior year.
- Depreciation & Amortization (CF) fell to $75108.2 in Q1 2026 per MCUJF's latest filing, from $86767.4 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $262994.0 in Q3 2022 and bottomed at $70863.4 in Q3 2023.
- The 5-year median for Depreciation & Amortization (CF) is $84019.8 (2023), against an average of $99790.5.
- Across the five-year window, Depreciation & Amortization (CF) surged 136.37% in 2022 and sank 73.06% in 2023, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $262994.0 in 2022, then plunged by 67.88% to $84471.6 in 2023, then decreased by 2.54% to $82322.7 in 2024, then increased by 5.4% to $86767.4 in 2025, then dropped by 13.44% to $75108.2 in 2026.
- Per Business Quant, the three latest MCUJF Depreciation & Amortization (CF) figures stand at $75108.2 (Q1 2026), $86767.4 (Q4 2025), and $100275.6 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 75,108.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,108.19 |
| Mar 31, 2026 | 75,108.19 |
| Dec 31, 2025 | 86,767.44 |
| Dec 31, 2025 | 86,767.44 |
| Sep 30, 2025 | 100,275.63 |
| Sep 30, 2025 | 100,275.63 |
| Jun 30, 2025 | 87,327.21 |
| Jun 30, 2025 | 87,327.21 |
| Mar 31, 2025 | 79,448.48 |
| Mar 31, 2025 | 79,448.48 |
| Dec 31, 2024 | 82,322.65 |
| Dec 31, 2024 | 82,322.65 |
| Sep 30, 2024 | 83,568.09 |
| Sep 30, 2024 | 83,568.09 |
| Jun 30, 2024 | 76,769.76 |
| Jun 30, 2024 | 76,769.76 |
| Mar 31, 2024 | 77,179.77 |
| Mar 31, 2024 | 77,179.77 |
| Dec 31, 2023 | 84,471.59 |
| Dec 31, 2023 | 84,471.59 |